- Home
- PRLD vs AIRT Comparison
PRLD vs AIRT Comparison
Compare PRLD & AIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- AIRT
- Stock Information
- Founded
- PRLD 2016
- AIRT 1980
- Country
- PRLD United States
- AIRT United States
- Employees
- PRLD N/A
- AIRT N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- AIRT Air Freight/Delivery Services
- Sector
- PRLD Health Care
- AIRT Consumer Discretionary
- Exchange
- PRLD Nasdaq
- AIRT Nasdaq
- Market Cap
- PRLD 69.1M
- AIRT 61.2M
- IPO Year
- PRLD 2020
- AIRT N/A
- Fundamental
- Price
- PRLD $1.36
- AIRT $22.07
- Analyst Decision
- PRLD Strong Buy
- AIRT
- Analyst Count
- PRLD 3
- AIRT 0
- Target Price
- PRLD $4.00
- AIRT N/A
- AVG Volume (30 Days)
- PRLD 3.2M
- AIRT 782.0
- Earning Date
- PRLD 10-31-2025
- AIRT 11-13-2025
- Dividend Yield
- PRLD N/A
- AIRT N/A
- EPS Growth
- PRLD N/A
- AIRT N/A
- EPS
- PRLD N/A
- AIRT N/A
- Revenue
- PRLD $7,000,000.00
- AIRT $296,309,000.00
- Revenue This Year
- PRLD N/A
- AIRT N/A
- Revenue Next Year
- PRLD N/A
- AIRT N/A
- P/E Ratio
- PRLD N/A
- AIRT N/A
- Revenue Growth
- PRLD N/A
- AIRT 5.14
- 52 Week Low
- PRLD $0.61
- AIRT $14.56
- 52 Week High
- PRLD $4.22
- AIRT $26.70
- Technical
- Relative Strength Index (RSI)
- PRLD 47.51
- AIRT 45.47
- Support Level
- PRLD $1.43
- AIRT $22.51
- Resistance Level
- PRLD $4.19
- AIRT $22.40
- Average True Range (ATR)
- PRLD 0.40
- AIRT 0.32
- MACD
- PRLD -0.01
- AIRT -0.06
- Stochastic Oscillator
- PRLD 6.44
- AIRT 6.00
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.